In the last trading session, 2.54 million Spero Therapeutics Inc (NASDAQ:SPRO) shares changed hands as the company’s beta touched 1.31. With the company’s per share price at $2.50 changed hands at -$0.06 or -2.34% during last session, the market valuation stood at $139.78M. SPRO’s last price was a discount, traded about -18.0% off its 52-week high of $2.95. The share price had its 52-week low at $0.51, which suggests the last value was 79.6% up since then.
Analysts gave the Spero Therapeutics Inc (SPRO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SPRO as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Spero Therapeutics Inc’s EPS for the current quarter is expected to be -0.32.
Spero Therapeutics Inc (NASDAQ:SPRO) trade information
However, in the 30-day time frame, Spero Therapeutics Inc (NASDAQ:SPRO) is 332.53% up.
Spero Therapeutics Inc (SPRO) estimates and forecasts
Year-over-year growth is forecast to reach -87.70% down from the last financial year.
The company’s revenue for the corresponding quarters a year ago was 10.2M and 13.47M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -100.00%. The estimates for the next quarter sales put growth at -100.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.67%. The 2025 estimates are for Spero Therapeutics Inc earnings to increase by 9.45%, but the outlook for the next 5-year period is at 7.97% per year.
SPRO Dividends
Spero Therapeutics Inc is expected to release its next quarterly earnings report in July.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.3079% or 1.77 million shares worth $2.3 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.17 shares estimated at $2.92 million under it, the former controlled 2.09% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.05% of the shares, roughly 587.34 shares worth around $1.47 million.
